Clinical Trial

TrueTear in Sjogren's Disease Patients

Study Description

TrueTear in Sjogren's Disease Patients

The purpose of this study is to evaluate acute tear production produced by the intranasal tear neurostimulator in participants with SjA?grens syndrome and aqueous tear deficiency. Our primary goal is to evaluate whether SjA?grens patients respond to this intervention and whether there is a baseline tear production level below which these patients do not respond.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - TrueTear Intranasal Tear Neurostimulator

This study will evaluate the immediate tear production resulting from use of intranasal tear neurostimulation in patients with Sjogren's disease

Additional Information

Official Study Title

Prospective Controlled Study of Intranasal Tear Neurostimulation for Sjogrens Patients With Dry Eye Disease

Clinical Trial ID

NCT03719885

ParticipAid ID

axklre